FORLINO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.459
AS - Asia 4.028
EU - Europa 3.068
SA - Sud America 645
AF - Africa 176
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.385
Nazione #
US - Stati Uniti d'America 5.333
CN - Cina 1.769
SG - Singapore 889
IE - Irlanda 724
VN - Vietnam 511
BR - Brasile 479
HK - Hong Kong 451
RU - Federazione Russa 410
FI - Finlandia 344
DE - Germania 327
IT - Italia 293
UA - Ucraina 249
FR - Francia 192
GB - Regno Unito 157
SE - Svezia 135
ZA - Sudafrica 112
IN - India 104
CA - Canada 59
AR - Argentina 49
MX - Messico 46
BE - Belgio 44
BD - Bangladesh 41
JP - Giappone 39
IQ - Iraq 31
CO - Colombia 30
PL - Polonia 30
EC - Ecuador 29
AT - Austria 28
NL - Olanda 27
TR - Turchia 27
CZ - Repubblica Ceca 24
ID - Indonesia 20
PK - Pakistan 18
SA - Arabia Saudita 18
CL - Cile 16
ES - Italia 16
VE - Venezuela 15
LT - Lituania 12
MA - Marocco 12
PY - Paraguay 12
IR - Iran 10
UZ - Uzbekistan 10
AL - Albania 8
KE - Kenya 8
RO - Romania 8
ET - Etiopia 7
KG - Kirghizistan 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
PE - Perù 6
PH - Filippine 6
PT - Portogallo 6
GR - Grecia 5
KR - Corea 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
NP - Nepal 4
SN - Senegal 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GA - Gabon 3
GE - Georgia 3
HR - Croazia 3
LV - Lettonia 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
CH - Svizzera 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 13.363
Città #
Dallas 864
Dublin 721
Chandler 666
Singapore 493
Ashburn 464
Hong Kong 444
San Jose 431
Beijing 403
Jacksonville 313
Nanjing 302
Ann Arbor 195
Boardman 182
Los Angeles 169
Ho Chi Minh City 168
Helsinki 140
Nanchang 120
Lauterbourg 118
Hanoi 117
Princeton 115
Munich 114
Lawrence 112
Wilmington 102
Johannesburg 101
Shenyang 99
Medford 97
Changsha 95
Pavia 90
Hebei 83
Shanghai 79
Moscow 77
New York 71
Jiaxing 68
Milan 64
Buffalo 62
Hangzhou 61
Redondo Beach 56
Tianjin 54
Woodbridge 50
São Paulo 47
Turku 47
Brussels 44
Houston 36
Orem 36
Tokyo 33
Da Nang 25
Santa Clara 25
Frankfurt am Main 24
Haiphong 24
Chennai 23
Montreal 23
Council Bluffs 22
Warsaw 22
The Dalles 21
Atlanta 20
Dearborn 20
Nuremberg 19
Washington 19
Fairfield 18
San Francisco 18
Seattle 18
Stockholm 18
Chicago 17
London 17
Norwalk 17
Toronto 17
Brooklyn 16
Belo Horizonte 14
Falkenstein 14
Rio de Janeiro 14
Verona 14
Vienna 14
Hải Dương 13
Quito 13
Baghdad 12
Brno 12
Denver 12
Jinan 12
Amsterdam 11
Boston 11
Des Moines 11
Poplar 11
Riyadh 11
Columbus 10
Guangzhou 10
Mumbai 10
Santiago 10
Biên Hòa 9
Brasília 9
Curitiba 9
Florence 9
Manchester 9
Medellín 9
New Delhi 9
Ninh Bình 9
Olomouc 9
Zhengzhou 9
Ankara 8
Auburn Hills 8
Buenos Aires 8
Mexico City 8
Totale 9.007
Nome #
Osteogenesis Imperfecta: A Look into the Cerebellum of the Brtl Murine Model 296
A Rare Cause of Lower Extremity Ulcers: Prolidase Deficiency 181
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 177
Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models 175
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 175
A Mn(II)-Mn(II) center in human prolidase 161
Cartilage histogenesis in a murine model of chondrodysplasia 156
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. 155
Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis 154
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 149
Matrix disruptions, growth, and degradation of cartilage with impaired sulfation. 147
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 143
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach 139
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 137
Alpha 1-antitrypsin activity in subarachnoid hemorrhage. 136
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 136
Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. 135
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 134
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 133
Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts 132
Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta 131
A 931 + 2T-->C transition in one COL1A2 allele causes exon 16 skipping in PRO alpha 2(I) mRNA and produces moderately severe OI. 130
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion 130
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate 130
Alteration of proteoglycan sulfation affects bone growth and remodeling. 129
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 128
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification 128
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 127
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome 127
Severely impaired bone material quality in chihuahua zebrafish resembles classical dominant human Osteogenesis Imperfecta 126
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 123
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 123
Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study 122
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 121
A base substitution at IVS-19 3'-end splice junction causes exon 20 skipping in pro alpha 2(I) collagen mRNA and produces mild osteogenesis imperfecta. 121
Prolidase enzyme is required for extracellular matrix integrity and impacts on postnatal cerebellar cortex development 121
Lack of prolidase causes a bone phenotype both in human and in mouse 120
Loss-of-Function FANCL Mutations Associate with Severe Fanconi Anemia Overlapping the VACTERL Association 119
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 119
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 118
A novel mutation in the sulphate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. 117
New perspectives on osteogenesis imperfecta. 116
Early Fracture Healing is Delayed in the Col1a2 +/G610C Osteogenesis Imperfecta Murine Model 116
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 115
Activity of alpha 1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm. 115
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 115
Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. 115
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 114
Loss-of-function FANCL mutations associate with severe fanconi anemia overlapping the VACTERL association 114
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 114
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. 113
Multiple effects of the Na(+)/H (+) antiporter inhibitor HMA on cancer cells. 113
Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes 113
Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype 112
Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC. 111
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 109
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 109
An alpha 2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta. 109
Identifying the structure of the active sites of human recombinant prolidase 106
A novel chemical chaperone ameliorates osteoblast homeostasis and extracellular matrix in osteogenesis imperfecta 106
Bone cell differentiation and mineralization in wild-type and osteogenesis imperfecta zebrafish are compromised by per- and poly-fluoroalkyl substances (PFAS) 105
Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective 105
Knocking out TMEM38B in human foetal osteoblasts hFOB 1.19 by CRISPR/Cas9: A model for recessive OI type XIV 104
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 103
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. 101
MCM5: A new actor in the link between DNA replication and Meier-Gorlin syndrome 96
Alternative splicing in COL1A1 mRNA leads to a partial null allele and two in-frame forms with structural defects in non-lethal osteogenesis imperfecta. 96
Brittle IV Mouse Model for Osteogenesis imperfecta IV Demonstrates Postpubertal Adaptations to Improve Whole Bone Strength. 95
Absence of Dipeptidyl Peptidase 3 increases oxidative stress and causes bone loss 95
XX males SRY negative: a confirmed cause of infertility 93
Prolidase deficiency may be reversed by hematopietic stem cell transplantation: CE analysis of dipeptides in urine and monitoring of prolidase activity in blood. 92
Novel RPL13 Variants and Variable Clinical Expressivity in a Human Ribosomopathy With Spondyloepimetaphyseal Dysplasia 91
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 91
PRKACB and Carney complex 90
HEM dysplasia and ichthyosis are likely laminopathies and not due to 3beta-hydroxysterol Delta14-reductase deficiency. 89
Evaluation of the TiMo12Zr6Fe2 alloy for orthopaedic implants: in vitro biocompatibility study by using primary human fibroblasts and osteoblasts 89
Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. 89
Characterization of stress response in human retinal epithelial cells. 89
Steady-state and pulse-chase analyses of fibrillar collagen 89
Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix. 88
Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta 88
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 87
Consortium of Osteogenesis Imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. 87
Molecular stability of chemically modified collagen triple helices 87
The administration of exogenous HSP47 as a collagen-specific therapeutic approach 85
Osteogenesis imperfecta 85
Zebrafish: A Resourceful Vertebrate Model to Investigate Skeletal Disorders 85
Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta. 84
Phenotypic characterization of immortalized chondrocytes from a desbuquois dysplasia type 1 mouse model: A tool for studying defects in glycosaminoglycan biosynthesis 84
Use of the Cre/Lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. 83
Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing. 83
More bone with less minerals? The effects of dietary phosphorus on the post-cranial skeleton in zebrafish 83
Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing 83
A standard set of outcome measures for the comprehensive assessment of osteogenesis imperfecta 83
Compression Fractures and Partial Phenotype Rescue With a Low Phosphorus Diet in the Chihuahua Zebrafish Osteogenesis Imperfecta Model 82
Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects. 81
CaMKII inhibition due to TRIC-B loss-of-function dysregulates SMAD signaling in osteogenesis imperfecta 80
Flavivirus antagonism of type i interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression 80
Prolidase Deficiency: case reports of two Argentinian brothers. 79
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 79
Totale 11.454
Categoria #
all - tutte 51.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 0 0 0 0 77 67 19
2021/2022538 9 13 10 12 10 6 14 39 29 14 80 302
2022/20231.920 185 177 12 150 199 155 7 114 831 18 46 26
2023/2024733 106 135 26 37 65 166 18 64 10 33 39 34
2024/20252.242 69 142 70 60 91 93 92 149 572 80 269 555
2025/20265.434 410 624 907 605 606 227 931 295 493 336 0 0
Totale 13.647